Irene Baker* is a care assistant at a psychiatric hospital in England. She describes the challenges of caring for mentally ill patients during the second wave of the COVID-19 pandemic.

A biologist explains what proteins do in viruses, how they interact with human cells, how the vaccine delivers mRNA into the cell and how antibodies protect us.

In a special one-off interview, PolioNews (PN) talks to both Aidan O’Leary (A-O’L) and Michel Zaffran (MZ) about the future of polio eradication.

Pfizer and Moderna’s COVID-19 vaccine candidates have turned the vaccine cold chain into hot news. But what is a cold chain? How does it work? And what does it have to do with equity?

We've gone from a novel virus to several COVID-19 vaccines in less than a year. Here's what we've learned from earlier vaccines to allow this to happen.

COVAX is forecasting it will roll out over 2 billion COVID-19 vaccine doses in 2021. What does that mean for the world’s poorest countries?

The world’s most comprehensive study reveals all! A new study looking at the impact of vaccinations in 98 countries over the past 20 years concludes that 37 million people are alive today thanks to vaccines.

Scientists are working to understand what mutations of the virus mean for inoculation strategies.

Australia is set to get the green light to roll out the Pfizer vaccine any day now. There is a complex process behind this.

To achieve universal sanitation, we need greater investment and higher rates of sanitation coverage.

New research adds to the argument that the global distribution of COVID-19 vaccines is the most optimal solution for a global economic recovery.

Don't panic if a second dose isn't available exactly when you need it.